These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36475547)
1. Pretreatment with a P2Y12 receptor inhibitor and delay to coronary artery bypass surgery in patients with non-ST segment elevation acute coronary syndrome. Gomes DA; Rocha BM; Ferreira J; Paiva MS; Reis Santos R; Santos MR; Cunha G; DE Araújo Gonçalves P; Fevereiro S; Trabulo M; Aguiar C; Sousa-Uva M; Neves J; Mendes M Minerva Cardiol Angiol; 2023 Oct; 71(5):582-589. PubMed ID: 36475547 [TBL] [Abstract][Full Text] [Related]
2. Precatheterization Use of P2Y Badri M; Abdelbaky A; Li S; Chiswell K; Wang TY J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939715 [TBL] [Abstract][Full Text] [Related]
3. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. Ebrahimi R; Dyke C; Mehran R; Manoukian SV; Feit F; Cox DA; Gersh BJ; Ohman EM; White HD; Moses JW; Ware JH; Lincoff AM; Stone GW J Am Coll Cardiol; 2009 May; 53(21):1965-72. PubMed ID: 19460609 [TBL] [Abstract][Full Text] [Related]
4. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638 [TBL] [Abstract][Full Text] [Related]
5. Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y Russo JJ; James TE; Ruel M; Dupuis JY; Singh K; Goubran D; Malhotra N; Rubens F; Chong AY; Hibbert B; Boland P; Tran DT; Tanguay JF; Lordkipanidzé M; Perrault L; Wells GA; Bourke M; Chan V; So DY Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):543-553. PubMed ID: 29313713 [TBL] [Abstract][Full Text] [Related]
6. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176 [TBL] [Abstract][Full Text] [Related]
9. Ticagrelor Utilization in Patients With Non-ST Elevation Acute Coronary Syndromes in Romania. Cotoban AG; Udroiu CA; Vinereanu D Am J Ther; 2021 Apr; 28(3):e271-e283. PubMed ID: 33852478 [TBL] [Abstract][Full Text] [Related]
10. Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes. Moon J; Ozaki AF; Chong A; Sud M; Fang J; Austin PC; Ko DT; Jackevicius CA Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5704. PubMed ID: 37771242 [TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127 [TBL] [Abstract][Full Text] [Related]
12. Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption. Johnston SS; Bell K; Gdovin J; Jing Y; Graham J Hosp Pract (1995); 2012 Feb; 40(1):15-23. PubMed ID: 22406879 [TBL] [Abstract][Full Text] [Related]
13. P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. Zeymer U; Widimsky P; Danchin N; Lettino M; Bardaji A; Barrabes JA; Cequier A; Claeys MJ; De Luca L; Dörler J; Erlinge D; Erne P; Goldstein P; Koul SM; Lemesle G; Lüscher TF; Matter CM; Montalescot G; Radovanovic D; Sendón JL; Tousek P; Weidinger F; Weston CF; Zaman A; Andell P; Li J; Jukema JW; Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):229-43. PubMed ID: 27533946 [TBL] [Abstract][Full Text] [Related]